10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Aspergillosis can show in a few shapes, each with its claim clinical characteristics and suggestions. Unfavorably susceptible bronchopulmonary aspergillosis (ABPA) could be a response to Aspergillus antigens, basically influencing people with asthma or cystic fibrosis. Constant aspiratory aspergillosis (CPA) may be a and possibly life-threatening lung disease that commonly happens in people with pre-existing lung conditions or compromised resistant frameworks. Obtrusive aspergillosis (IA) is the foremost extreme shape of the disease, ordinarily influencing seriously immunocompromised people, such as those experiencing chemotherapy or organ transplantation. IA can spread past the lungs and influence other organs, driving to systemic complications and tall mortality rates in the event that not instantly treated with antifungal treatment. Early conclusion and suitable administration are significant for making strides results in patients with all shapes of aspergillosis.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States